Sridhar Guduri
Expertise in
3
conditions

Dr. Sridhar Guduri

Allergy and Immunology
Psf PLLC
3915 Berry Leaf Ln, 
Hilliard, OH 
Accepting New Patients
Expertise in
3
conditions
Psf PLLC
3915 Berry Leaf Ln, 
Hilliard, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sridhar Guduri is an Allergy and Immunologist in Hilliard, Ohio. Dr. Guduri is highly rated in 3 conditions, according to our data. His top areas of expertise are Allergic Rhinitis, Sinusitis, Grass Allergy, and Chronic Spontaneous Urticaria (CSU). Dr. Guduri is currently accepting new patients.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in OH
Languages Spoken
English
Hindi
Telugu
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

PSF PLLC
3915 Berry Leaf Ln, Hilliard, OH 43026
Other Locations
PSF PLLC
8080 Ravines Edge Ct, Suite 100, Columbus, OH 43235
PSF PLLC
6275 E Broad St, Suite 100, Columbus, OH 43213
PSF PLLC
209 Rivers Edge Dr, Milford, OH 45150
PSF PLLC
3 Health Dr, Chillicothe, OH 45601
PSF PLLC
1524 W Church St, Newark, OH 43055

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Drug
Study Drug: CNP-201
Study Phase: Phase 1
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase IV, 12 Week, Randomised, Double-blind, Double-dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI), With Tiotropium Monotherapy Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
A Phase IV, 12 Week, Randomised, Double-blind, Double-dummy Study to Compare Single Inhaler Triple Therapy, Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI), With Tiotropium Monotherapy Based on Lung Function and Symptoms in Participants With Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Drug, Device
Study Phase: Phase 4
View 5 Less Clinical Trials
Similar Doctors
Monica T. Kraft
Expertise in
10
conditions
Dr. Monica T. Kraft
Allergy and Immunology
Expertise in
10
conditions
Dr. Monica T. Kraft
Allergy and Immunology

Osu Otolaryngology Head And Neck Surgery LLC

915 Olentangy River Rd, 
Columbus, OH 
 (7.7 miles away)
614-366-3687
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monica Kraft is an Allergy and Immunologist in Columbus, Ohio. Dr. Kraft is highly rated in 10 conditions, according to our data. Her top areas of expertise are Asthma, Eosinophilic Asthma, Anaphylaxis, and Allergic Rhinitis. Dr. Kraft is currently accepting new patients.

Expertise in
13
conditions
Dr. Scott E. Bagenstose
Allergy and Immunology
Expertise in
13
conditions
Dr. Scott E. Bagenstose
Allergy and Immunology

Ohio ENT & Allergy Physicians

3545 Olentangy River Rd, Suite 200, 
Columbus, OH 
 (6.1 miles away)
614-827-0021
Languages Spoken:
English
See accepted insurances

Scott Bagenstose is an Allergy and Immunologist in Columbus, Ohio. Dr. Bagenstose is highly rated in 13 conditions, according to our data. His top areas of expertise are Sinusitis, Allergic Rhinitis, Grass Allergy, and Allergic Conjunctivitis.

Expertise in
8
conditions
Dr. Donald L. Mcneil
Allergy and Immunology
Expertise in
8
conditions
Dr. Donald L. Mcneil
Allergy and Immunology

Ohiohealth Corporation

3595 Olentangy River Rd, 
Columbus, OH 
 (6.2 miles away)
614-566-5377
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald Mcneil is an Allergy and Immunologist in Columbus, Ohio. Dr. Mcneil is highly rated in 8 conditions, according to our data. His top areas of expertise are Primary Immunodeficiency (PID), Common Variable Immune Deficiency, Allergic Rhinitis, and Sinusitis. Dr. Mcneil is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Guduri's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile